Marlin W Johnston Net Worth

The estimated Net Worth of Marlin W Johnston is at least $2.78 Million dollars as of 28 November 2012. Marlin Johnston owns over 8,442 units of U.S. Physical Therapy stock worth over $2,429,259 and over the last 21 years Marlin sold USPH stock worth over $345,799.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Marlin Johnston USPH stock SEC Form 4 insiders trading

Marlin has made over 5 trades of the U.S. Physical Therapy stock since 2011, according to the Form 4 filled with the SEC. Most recently Marlin sold 8,442 units of USPH stock worth $221,349 on 28 November 2012.

The largest trade Marlin's ever made was exercising 22,500 units of U.S. Physical Therapy stock on 26 November 2012 worth over $379,350. On average, Marlin trades about 2,426 units every 30 days since 2003. As of 28 November 2012 Marlin still owns at least 29,240 units of U.S. Physical Therapy stock.

You can see the complete history of Marlin Johnston stock trades at the bottom of the page.

What's Marlin Johnston's mailing address?

Marlin's mailing address filed with the SEC is 1300 W. SAM HOUSTON PKWAY S., SUITE 300, HOUSTON, TX, 77042.

Insiders trading at U.S. Physical Therapy

Over the last 23 years, insiders at U.S. Physical Therapy have traded over $77,674,124 worth of U.S. Physical Therapy stock and bought 127,370 units worth $3,593,373 . The most active insiders traders include Bruce D Broussard, Roy W Spradlin, and Christopher J Reading. On average, U.S. Physical Therapy executives and independent directors trade stock every 22 days with the average trade being worth of $787,765. The most recent stock trade was executed by Kathleen A Gilmartin on 3 September 2024, trading 2,000 units of USPH stock currently worth $172,180.

What does U.S. Physical Therapy do?

u.s. physical therapy is a publicly held company that operates hundreds of outpatient physical and occupational therapy clinics in over 40 states. the company's clinics provide acute, post-operative, and preventative care for a variety of orthopedic and neurologic disorders including sports and work related injuries. the unique nature of the company is its operating structure - the company's clinics are developed and operated through partnerships with therapists who share in the clinic's profits. in addition to the therapist partnership model, u.s. physical therapy also buys into existing physical therapy practices.

Complete history of Marlin Johnston stock trades at U.S. Physical Therapy

U.S. Physical Therapy executives and stock owners

U.S. Physical Therapy executives and other stock owners filed with the SEC include:

• Christopher Reading,
  President, Chief Executive Officer, Director
• Lawrance McAfee,
  Director
• Graham Reeve,
  Chief Operating Officer - East
• Glenn McDowell,
  Chief Operating Officer - West
• Christopher J. Reading,
  Pres, CEO & Director
• Graham D. Reeve M.B.A., P.T.,
  Chief Operating Officer of East
• Glenn D. McDowell,
  Chief Operating Officer of West
• Carey P. Hendrickson,
  Chief Financial Officer
• Reginald Swanson,
  Director
• Clayton Trier,
  Independent Director
• Harry Chapman,
  Independent Director
• Edward Kuntz,
  Independent Chairman of the Board
• Bernard Harris,
  Independent Director
• Mark Brookner,
  Independent Director
• Kathleen Gilmartin,
  Independent Director
• Carey Hendrickson,
  Chief Financial Officer
• Jason Anderson,
  VP of HR
• Jayne Fleck Pool ATC, PT, SCS,
  Sr. VP & Chief Compliance Officer
• Chadd Pence,
  Sr. VP of Information Systems
• Jake Martinez,
  Sr. VP of Fin. & Accounting
• Johnny J. Blanchard,
  Assistant Controller
• Jon C. Bates,
  VP & Corp. Controller
• Eric Joseph Williams,
  Co-Chief Operating Officer - West
• Richard S. Binstein,
  Exec. VP, Gen. Counsel & Sec.
• Marlin W Johnston,
  Director
• Jerald L Pullins,
  Director
• Eric Joseph Williams,
  Co-Chief Operations Officer
• Regg E. Swanson,
  
• Anne Motsenbocker,
  
• Nancy Ham,
  
• Bruce D Broussard,
  Director
• James B Hoover,
  Director
• Daniel C Arnold,
  Director
• Albert L Rosen,
  Director
• J Livingston Kosberg,
  CEO and President
• Roy W Spradlin,
  Chairman, President, CEO
• Michael Lewis Lang,
  Sr. VP of Development
• Richard Binstein,
  EVP Gen'l Counsel & Secretary